Application of human recombination protein PDCD5 in preparing tumor chemotherapy sensitizing medicine
A technology of human recombination and protein, which is applied in the direction of anti-tumor drugs, peptide/protein components, drug combinations, etc., and can solve the problems of limiting chemotherapy and the toxic effects of chemotherapy drugs
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0031] Embodiment 1, construction PDCD5 Escherichia coli expression plasmid
[0032] According to the cDNA and protein sequences of the PDCD5 coding region (see Chinese patent application: ZL98101869.6, publication number CN1218833A), PDCD5 was directional inserted into the pET30a vector (purchased from Novagen) using the NdeI and HindIII sites to obtain the pET30a-PDCD5 expression vector. After the correctness of the plasmid was verified by sequencing, the BL21 strain was transformed.
Embodiment 2
[0033] Embodiment 2, expression and purification of PDCD5 in Escherichia coli
[0034] After the ET30a-PDCD5 expression vector was transformed into BL21(DE3) Escherichia coli and amplified, 1mMIPTG (isopropyl-β-D-thiogalactoside) (Sigma-Aldrich) induced the expression of human recombinant PDCD5 protein, which was anion-exchanged with DEAE Chromatography (Amersham Pharmacia Biotech) and hydrophobic chromatography (Amersham Pharmacia Biotech) to obtain PDCD5 purified protein. used in the following experiments.
[0035] The results are shown in FIG. 1 , by densitometric scanning, the expression level of the target protein PDCD5 is about 8%. Most of the protein was expressed in the supernatant form. As shown in Figure 2, by exploring and optimizing the separation and purification conditions, after two-step purification by ion exchange and hydrophobic chromatography, human recombinant PDCD5 protein with a purity greater than 95% at the electrophoretic level can be obtained.
Embodiment 3
[0036] Embodiment 3, PDCD5 internalization kinetics
[0037] HEK293 and U937 cells (purchased from ATCC) were cultured in RPMI containing 10% heat-inactivated fetal bovine serum (FBS) (Hyclone, USA), 100 U / ml penicillin, 100 μg / ml streptomycin, 2 mM L-glutamic acid 1640 (Life Technologies, USA). HEK293 cells are an adherent-growing cell expressing caveolin-1, and U937 cells are a suspension-growing cell that does not express caveolin-1.
[0038] Human recombinant PDCD5 protein was labeled with fluorescein isothiocyanate (FITC) in 0.025M carbonate buffer (pH9.0), and then purified by Sephadex G25 to remove free FITC , to obtain PDCD5-FITC protein.
[0039] Flow cytometric analysis of the internalization of FITC-labeled PDCD5 recombinant protein: Culture HEK293 and U937 cells to 70% in 24-well plates, and then incubate with 5 μg / ml recombinant PDCD5-FITC. The incubation time points are shown in the figure (Figure 3) . The cells were washed twice with PBS, treated with trypsi...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com